Advanced Instruments Exhibits New Products and Technologies at AACC
|
By LabMedica International staff writers Posted on 31 Jul 2018 |
|
Image: The Osmo1 single-sample micro-osmometer (Photo courtesy of Advanced Instruments).
Advanced Instruments (Norwood, MA, USA) exhibited its new Osmo1 single-sample micro-osmometer, alongside its full line of instrumentation for clinical laboratories, including the Anoxomat III jar system and GloCyte automated cell counter system, at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo. Advanced Instruments, a developer of scientific and analytical instruments for the clinical industry, provides solutions and support to the clinical laboratory market.
The new Osmo1 single-sample micro-osmometer can measure the osmolality of specimens, including urine, serum, plasma, stool, and other body fluids, and uses a small 20 μL sample size. It offers workflow efficiency, result security and integrity, connectivity, quality control, and audit control for today’s busy clinical laboratories.
The Anoxomat III is an easy-to-use jar system for microbiology laboratories with the ability to create anaerobic, microaerophilic, and custom environments – such as capnophilic – within a few minutes. The quality control process checks the jar to ensure that there is no leakage and the catalyst is working, and provides the end user with documentation that the jar is under the appropriate environment before the incubation starts. The Anoxomat system offers shorter test times, improved workflow, and reduced operational costs for laboratories.
The GloCyte automated cell counter system combines fluorescence and imaging technology to deliver highly accurate and precise counts of total nucleated cells (TNCs) and red blood cells (RBCs) in cerebrospinal fluid samples. It is the only system that is linear down to 0 cells/μL and has a limit of detection of 1 cell/μL for both RBC and TNC. The GloCyte system requires a small sample volume of only 30 micro liters per test, minimizes manual errors with LIS connectivity, and features a built in quality control system that ensures accurate and precise results.
"Advanced Instruments is committed to supporting patient care by providing innovative technologies that meet the needs of clinical laboratories while helping improve workflow efficiencies," said Byron Selman, CEO of Advanced Instruments. "We look forward to introducing lab techs, managers, and directors to the new products in our portfolio that can contribute to their future success."
The new Osmo1 single-sample micro-osmometer can measure the osmolality of specimens, including urine, serum, plasma, stool, and other body fluids, and uses a small 20 μL sample size. It offers workflow efficiency, result security and integrity, connectivity, quality control, and audit control for today’s busy clinical laboratories.
The Anoxomat III is an easy-to-use jar system for microbiology laboratories with the ability to create anaerobic, microaerophilic, and custom environments – such as capnophilic – within a few minutes. The quality control process checks the jar to ensure that there is no leakage and the catalyst is working, and provides the end user with documentation that the jar is under the appropriate environment before the incubation starts. The Anoxomat system offers shorter test times, improved workflow, and reduced operational costs for laboratories.
The GloCyte automated cell counter system combines fluorescence and imaging technology to deliver highly accurate and precise counts of total nucleated cells (TNCs) and red blood cells (RBCs) in cerebrospinal fluid samples. It is the only system that is linear down to 0 cells/μL and has a limit of detection of 1 cell/μL for both RBC and TNC. The GloCyte system requires a small sample volume of only 30 micro liters per test, minimizes manual errors with LIS connectivity, and features a built in quality control system that ensures accurate and precise results.
"Advanced Instruments is committed to supporting patient care by providing innovative technologies that meet the needs of clinical laboratories while helping improve workflow efficiencies," said Byron Selman, CEO of Advanced Instruments. "We look forward to introducing lab techs, managers, and directors to the new products in our portfolio that can contribute to their future success."
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
New
Homocysteine Quality Control
Liquichek Homocysteine Control
8-Channel Pipette
SAPPHIRE 20–300 µL
Latest AACC 2018 News
- Mesa Biotech Showcases PCR Testing Platform at Clinical Expo
- Mindray Medical Unveils Chemiluminescence Immunoassay System at AACC 2018
- Abbott Diagnostics Displays Alinity Family of Systems
- Roche Diagnostics Highlights Latest Clinical Lab Solutions at AACC
- Sysmex Highlights Innovations in Flow Cytometry, Urinalysis and Hematology
- Ortho Clinical Diagnostics Unveils Next-Gen Analyzer at Lab Show
- Snibe Diagnostic Presents Immunoassay Systems and Biochemistry Analyzers
- Thermo Fisher Scientific Showcases Product Portfolio at Lab Trade Show
- EKF Diagnostics Highlights Assay Kit and POC Analyzer at AACC 2018
- Randox Laboratories Showcases Advances in Biotechnology at Clinical Lab Expo
- Beckman Coulter Life Sciences Highlights Clinical Flow Cytometry Portfolio
- Beckman Coulter Features New Hematology Analyzers and Lab Automation
- Carolina Liquid Chemistries Promotes Family of Clinical Chemistry Analyzers
- Orion Diagnostica Showcases Rapid Test and Molecular Platform at Lab Show
- Saladax Biomedical Launches Game-Changing Assays at AACC 2018
- SeraCare Life Sciences Promotes New AccuSpan Panel at Lab Expo
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read more
Molecular Diagnostics
view channel
Simple Urine Test to Revolutionize Bladder Cancer Diagnosis and Treatment
Bladder cancer is one of the most common and deadly urological cancers and is marked by a high rate of recurrence. Diagnosis and follow-up still rely heavily on invasive cystoscopy or urine cytology, which... Read more
Blood Test to Enable Earlier and Simpler Detection of Liver Fibrosis
Persistent liver damage caused by alcohol misuse or viral infections can trigger liver fibrosis, a condition in which healthy tissue is gradually replaced by collagen fibers. Even after successful treatment... Read more
Hematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Immunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read more
Microbiology
view channel
Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read more
Rapid POC Tuberculosis Test Provides Results Within 15 Minutes
Tuberculosis remains one of the world’s deadliest infectious diseases, and reducing new cases depends on identifying individuals with latent infection before it progresses. Current diagnostic tools often... Read more
Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read more
Pathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read more
AI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read more
Technology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read more
Industry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more
